Michael Rosenthal

10PUBLICATIONS
78CO-AUTHORS
Predictive and prognostic markersMolecular targetsSemi- and unsupervised learningMedical biochemistry - proteins and peptides (incl. medical proteomics)Cancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Jan 19, 2026
Plasma cell-free DNA markers predict occult metastases in patients with resectable pancreatic ductal adenocarcinoma.

Jacob E Till, Ofer Gal-Rosenberg, Sophia G Giliberto

|Jan 18, 2024
Sotorasib Is a Pan-RASG12C Inhibitor Capable of Driving Clinical Response in NRASG12C Cancers.

Douglas A Rubinson, Noritaka Tanaka, Ferran Fece de la Cruz

|Jul 18, 2023
Adipose tissue and skeletal muscle wasting precede clinical diagnosis of pancreatic cancer.

Ana Babic, Michael H Rosenthal, Tilak K Sundaresan

|Jul 18, 2023
Oncogenic Drivers and Therapeutic Vulnerabilities in KRAS Wild-Type Pancreatic Cancer.

Harshabad Singh, Rachel B Keller, Kevin S Kapner

|May 03, 2021
Preparing Radiologists to Lead in the Era of Artificial Intelligence: Designing and Implementing a Focused Data Science Pathway for Senior Radiology Residents.

Walter F Wiggins, M Travis Caton, Kirti Magudia

|Jan 29, 2021
Associations of Skeletal Muscle With Symptom Burden and Clinical Outcomes in Hospitalized Patients With Advanced Cancer.

Emily van Seventer, J Peter Marquardt, Amelie S Troschel

Pageof 2

Frequent Collaborators

4 joint publications

Lauren K Brais

3 joint publications

Andrew J Aguirre

3 joint publications

Kimmie Ng

3 joint publications

Douglas A Rubinson